Evidence map›Paper›PMID 42064209›Full record

ArticleFrontiers in cellular and infection microbiology2026

Identification of risk factors and construction of a prediction model for multidrug-resistant organism infections in neutropenic patients.

Dian Jin, Qianqian Yang, Wenxiu Shu, Jing Le, Bingrong Chen

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dian JinDepartment of Hematology, Ningbo Medical Center Lihuili Hospital, Ningbo, China.
Qianqian YangDepartment of Hematology, Ningbo Medical Center Lihuili Hospital, Ningbo, China.
Wenxiu ShuDepartment of Hematology, Ningbo Medical Center Lihuili Hospital, Ningbo, China.
Jing LeDepartment of Hematology, Ningbo Medical Center Lihuili Hospital, Ningbo, China.
Bingrong ChenDepartment of Hematology, Ningbo Medical Center Lihuili Hospital, Ningbo, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Multidrug-resistant organisms (MDROs) pose a severe threat to neutropenic patients with compromised immunity, leading to poor outcomes and increased healthcare burdens. This study aimed to develop and validate a prediction model for MDRO infections in this population. Methods: A total of 391 neutropenic patients (206 in training cohort, 185 in validation cohort) admitted to Ningbo Medical Center Lihuili Hospital, from January 2023 to December 2024 were enrolled. Demographic, clinical, and outcome data were collected. The least absolute shrinkage and selection operator (LASSO) regression and multivariate logistic regression analyses were used to identify independent risk factors, and a nomogram was constructed for prediction. Model performance was evaluated via receiver operating characteristic (ROC),calibration curves and decision curve analysis (DCA). Results: MDRO infection occurred in 14.1% of patients, associated with longer hospital stays, higher costs, and increased mortality. Independent risk factors included comorbid cardiac disease (OR = 13.500, 95%CI: 2.484-73.384, P = 0.003), ECOG score≥2 (OR = 3.210, 95%CI: 1.114-9.255, P = 0.031), neutropenia duration≥7 days (OR = 4.028, 95%CI: 1.399-11.600, P = 0.010), and broad-spectrum antibiotic use in 3 months prior (OR = 13.053, 95%CI: 2.419-70.441, P = 0.003). The nomogram demonstrated good discriminative ability, with an area under the ROC curve of 0.874 in the training cohort and 0.764 in the validation cohort. Calibration curves confirmed favorable prediction accuracy and the DCA showed good clinical applicability. Conclusions: This study identifies key risk factors and provides a practical predictive tool for early identification of high-risk patients, enabling targeted interventions to reduce MDRO infections, improve patient outcomes, and alleviate healthcare burdens.

Indexed as

Bacterial InfectionsDrug Resistance, Multiple, BacterialNeutropeniaAdultAgedAnti-Bacterial AgentsFemaleHumansMaleMiddle AgedNomogramsRisk FactorsROC CurveAnti-Bacterial Agentsinfectionmultidrug-resistant organismneutropeniaprediction modelrisk factors

Identifiers

PMID42064209
PMCPMC13125032

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.